148 related articles for article (PubMed ID: 10948638)
1. [The new low-dose contraceptive Logest--first impressions].
Sirakov M
Akush Ginekol (Sofiia); 2000; 39 Suppl 1():19-20. PubMed ID: 10948638
[No Abstract] [Full Text] [Related]
2. [Novel low-dose contraceptive - one-year's experience with Logest].
Sirakov M
Akush Ginekol (Sofiia); 2000; 40 Suppl 3():15-6. PubMed ID: 11519224
[No Abstract] [Full Text] [Related]
3. [Clinical study of a low-dose contraceptive--Femodene].
Rachev E; Damianov L; Dukovski A; Katsarova M
Akush Ginekol (Sofiia); 1995; 34(3):71-3. PubMed ID: 8787249
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of desogestrel, the first new-generation progestagen, practil 21, on 13,290 women and 74,967 cycles].
Bilotta P; Favilli S
Minerva Ginecol; 1987 Dec; 39(12):855-69. PubMed ID: 3329705
[No Abstract] [Full Text] [Related]
5. [The effectiveness and acceptability of oral contraceptives (Logest), containing 20 micrograms ethinylestradiol and 75 micrograms gestodene].
Lech MM; Swiatek EJ
Ginekol Pol; 2004 Mar; 75(3):209-14. PubMed ID: 15181879
[TBL] [Abstract][Full Text] [Related]
6. Third generation oral contraceptives containing desogestrel and gestodene and the risk of thrombosis.
Griffin JP
Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):5-7. PubMed ID: 8920631
[No Abstract] [Full Text] [Related]
7. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Hoppe G
Contraception; 1987 Mar; 35(3):299-305. PubMed ID: 2956056
[No Abstract] [Full Text] [Related]
8. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Meurer LN; Slawson JG
J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
[No Abstract] [Full Text] [Related]
9. [Sexual abstinence of thrombosis? Comment on the controversy regarding the "pill of the 3rd generation"].
Strobel E
Fortschr Med; 1995 Nov; 113(33):18, 20. PubMed ID: 8575701
[No Abstract] [Full Text] [Related]
10. [Oral contraceptives and risk of myocardial infarction].
Sørensen MB; Ottesen BS
Ugeskr Laeger; 2002 Apr; 164(18):2415-6. PubMed ID: 12024850
[No Abstract] [Full Text] [Related]
11. Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components.
Jick SS; Myers MW; Jick H
Lancet; 1999 Jul; 354(9175):302-3. PubMed ID: 10440310
[TBL] [Abstract][Full Text] [Related]
12. Third generation oral contraceptives.
Skegg DC
BMJ; 2000 Jul; 321(7255):190-1. PubMed ID: 10903631
[No Abstract] [Full Text] [Related]
13. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
Barbosa IC; Filho CI; Faggion D; Baracat EC
Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291
[TBL] [Abstract][Full Text] [Related]
14. Risk of acute myocardial infarction and low-dose combined oral contraceptives.
Jick H; Jick S; Myers MW; Vasilakis C
Lancet; 1996 Mar; 347(9001):627-8. PubMed ID: 8596366
[No Abstract] [Full Text] [Related]
15. [Effect and control of oral contraceptive Minesse (15 mkg EE/60 mkg Gestoden) on menstrual cycle and body weight].
Krŭsteva
Akush Ginekol (Sofiia); 2003; 42(5):46-8. PubMed ID: 14682015
[No Abstract] [Full Text] [Related]
16. [Gestagens have become of great clinical value. Disadvantages are irregular bleeding and bad temper].
Landgren BM
Lakartidningen; 1999 Mar; 96(13):1578-81. PubMed ID: 10218339
[No Abstract] [Full Text] [Related]
17. [Hormonal contraception with gestagens].
Petersen KR; Poulsen EF
Ugeskr Laeger; 2001 Aug; 163(34):4553-6. PubMed ID: 11530558
[No Abstract] [Full Text] [Related]
18. Drospirenone (Slynd) - a new progestin-only oral contraceptive.
Med Lett Drugs Ther; 2020 Feb; 62(1591):18-19. PubMed ID: 32022787
[No Abstract] [Full Text] [Related]
19. Safety and efficacy of a new oral contraceptive containing drospirenone.
Shulman LP
J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives and venous thromboembolism.
Graham A; Grieve F; Davie J; Glasier A
Lancet; 1995 Nov; 346(8987):1430. PubMed ID: 7475846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
